Exercise or conversion
Jim Wassil
EVP, Chief Scientific Ofc, COO
Common Stock
- Value context
- $96.3K
- Reported price
- $5.35 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Vaxcyte, Inc.
Last 30 daysNo qualifying insider buying. Sales: $3.5M by 2 insiders.
Showing the first 6 of 20 trades on this page.
EVP, Chief Scientific Ofc, COO
Common Stock
EVP, Chief Scientific Ofc, COO
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
SVP, Finance & CAO
Common Stock
SVP, Finance & CAO
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
EVP, Chief Scientific Ofc, COO
Common Stock
EVP, Chief Scientific Ofc, COO
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
CHIEF EXECUTIVE OFFICER
Common Stock
PRESIDENT AND CFO
Common Stock
Chief Technical Ops Officer
Common Stock
SVP, Finance & CAO
Common Stock
EVP, Chief Scientific Ofc, COO
Common Stock
Chief Medical Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Medical Officer
Stock Option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
CHIEF OPERATING OFFICER
Common Stock
CHIEF OPERATING OFFICER
Common Stock
CHIEF OPERATING OFFICER
Common Stock
CHIEF OPERATING OFFICER
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
CHIEF EXECUTIVE OFFICER
Common Stock
CHIEF EXECUTIVE OFFICER
Common Stock
PRESIDENT AND CFO
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| EVP, Chief Scientific Ofc, COO | Common StockOption exercise or conversion10b5-1 | 18,000$5.35 / share | $96.3K | Oct 5Filed Oct 7 · 2d later | SEC filing |
| EVP, Chief Scientific Ofc, COO | Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units18,000$5.35 exercise / conversion price | Not a separate purchase | Oct 5Filed Oct 7 · 2d later | SEC filing |
| SVP, Finance & CAO | Common StockOption exercise or conversion10b5-1 | 19,000$25.92 / share | $492.48K | Oct 5Filed Oct 7 · 2d later | SEC filing |
| SVP, Finance & CAO | Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units19,000$25.92 exercise / conversion price | Not a separate purchase | Oct 5Filed Oct 7 · 2d later | SEC filing |
| EVP, Chief Scientific Ofc, COO | Common StockOption exercise or conversion10b5-1 | 2,250$5.35 / share | $12.04K | Oct 1Filed Oct 2 · 1d later | SEC filing |
| EVP, Chief Scientific Ofc, COO | Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units2,250$5.35 exercise / conversion price | Not a separate purchase | Oct 1Filed Oct 2 · 1d later | SEC filing |
| CHIEF EXECUTIVE OFFICER | Common StockExercise-price or tax withholding | 17,056$60.36 / share | $1.03M | Sep 8Filed Sep 9 · 1d later | SEC filing |
| PRESIDENT AND CFO | Common StockExercise-price or tax withholding | 7,155$60.36 / share | $431.88K | Sep 8Filed Sep 9 · 1d later | SEC filing |
| Chief Technical Ops Officer | Common StockExercise-price or tax withholding | 7,651$60.36 / share | $461.81K | Sep 8Filed Sep 9 · 1d later | SEC filing |
| SVP, Finance & CAO | Common StockExercise-price or tax withholding | 1,327$60.36 / share | $80.1K | Sep 8Filed Sep 9 · 1d later | SEC filing |
| EVP, Chief Scientific Ofc, COO | Common StockExercise-price or tax withholding | 5,459$60.36 / share | $329.51K | Sep 8Filed Sep 9 · 1d later | SEC filing |
| Chief Medical Officer | Common StockGrant or award | 52,632Award · no purchase price | Non-cash award | Sep 4Filed Sep 9 · 5d later | SEC filing |
| Chief Medical Officer | Stock Option (right to buy)Grant or award | Derivative units88,254Award · no purchase price | Non-cash award | Sep 4Filed Sep 9 · 5d later | SEC filing |
| CHIEF OPERATING OFFICER | Common StockExercise-price or tax withholding | 1,273$60.74 / share | $77.32K | Aug 31Filed Sep 2 · 2d later | SEC filing |
| CHIEF OPERATING OFFICER | Common StockOption exercise or conversion | 2,250$5.35 / share | $12.04K | Sep 1Filed Sep 2 · 1d later | SEC filing |
| CHIEF OPERATING OFFICER | Common StockExercise-price or tax withholding | 1,432$61.58 / share | $88.18K | Sep 2Filed Sep 2 · 0d later | SEC filing |
| CHIEF OPERATING OFFICER | Stock Option (right to buy)Option exercise or conversion | Derivative units2,250$5.35 exercise / conversion price | Not a separate purchase | Sep 1Filed Sep 2 · 1d later | SEC filing |
| CHIEF EXECUTIVE OFFICER | Common StockExercise-price or tax withholding | 2,862$60.74 / share | $173.84K | Aug 31Filed Sep 2 · 2d later | SEC filing |
| CHIEF EXECUTIVE OFFICER | Common StockExercise-price or tax withholding | 3,427$61.58 / share | $211.03K | Sep 2Filed Sep 2 · 0d later | SEC filing |
| PRESIDENT AND CFO | Common StockExercise-price or tax withholding | 1,273$60.74 / share | $77.32K | Aug 31Filed Sep 2 · 2d later | SEC filing |
Showing the latest 20 of 61 trades. Show all 61 trades
Vaxcyte, Inc. - Common Stock (PCVX) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberVaxcyte, Inc. - Common Stock (PCVX) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberVaxcyte, Inc. - Common Stock (PCVX) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberNo eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.